TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

17 hedge funds and large institutions have $725K invested in Theriva Biologics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$14.4K
2
+$7.46K
3
+$1.52K

Top Sellers

1
-$13K
2
-$5.45K
3
-$2.31K
4
Morgan Stanley
Morgan Stanley
New York
-$305
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$367K
2
$133K
3
$81.2K
4
$34K
5
$24.9K
6
$24K
7
$19.9K
8
$14.4K
9
$9.47K
10
$8.78K
11
$7.46K
12
$572
13
$77
14
$32
15
$14
16
$10
17
$7
18
–
19
–
20
–
21
–